Introduction
Obesity represents a growing public health challenge, with an estimated prevalence of 34.9% of U.S. adults, or 78.6 million people. 1 On an economic level, Americans spend 147 billion dollars annually to combat the health-related medical problems attributed to obesity. 2 The World Health Organization (WHO) defines obesity by calculating the body mass index (BMI). This measure is derived from dividing weight in kilograms by height in meters squared. Individuals with a BMI between 25 and 29.9 kg/m 2 are classified as overweight. Those with a BMI between 30 and 40 kg/m 2 are obese, and those with BMIs >40 kg/m 2 are considered morbidly obese. Obesity is associated with a litany of medical comorbidities including diabetes mellitus, hypertension, osteoarthritis, obstructive sleep apnea, and depression. [3] [4] [5] Though the effects on overall health are well documented, a growing body of literature suggests that obesity may contribute to increased rates of disk degeneration, spinal arthritis, and low back pain. 3, [6] [7] [8] As the incidence of obesity continues to rise in the general population, spine surgeons will undoubtedly perform more surgical procedures on these individuals. The purpose of this article
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Objective The aim of this literature review is to examine the effects of obesity on postoperative complications and functional outcomes after spine surgery. Methods A review of the relevant literature examining the effects of obesity and spine surgery was conducted using PubMed, Google Scholar, and Cochrane databases.
Results Obesity contributes to disk degeneration and low back pain and potentially increases the risk of developing operative pathology. Obese patients undergoing spine surgery have a higher risk of developing postoperative complications, particularly surgical site infection and venous thromboembolism. Though functional outcomes in this population may not mirror the general population, the treatment effect associated with surgery is at least equivalent if not better in obese individuals. This reduction is primarily due to worse outcomes associated with nonoperative treatment in the obese population.
Conclusion Obese individuals represent a unique patient population with respect to nonoperative treatment, postoperative complication rates, and functional outcomes. However, given the equivalent or greater treatment effect of surgery, this comorbidity should not prohibit obese patients from undergoing operative intervention. Future investigations in this area should attempt to develop strategies to minimize complications and improve outcomes in obese individuals and also examine the role of controlled weight loss preoperatively to mitigate these risks.
is to detail the effects obesity has on the adult spine as well as the effects on postoperative complication rates and functional outcomes in individuals undergoing spine surgery through a review of the existing literature.
Effects on the Spinal Column
Obesity has been linked with increased rates of disk degeneration, low back pain, sciatica, and spine surgery. [9] [10] [11] [12] [13] In a review of magnetic resonance imaging of the spine in 975 individuals, Teraguchi et al reported a significantly higher incidence of disk degeneration in the cervical (odds ratio [OR]: 1.60; p < 0.05), thoracic (OR: 3.12; p < 0.0001), and lumbar spine (OR: 2.56; p < 0.05) in obese subjects. 11 In a separate meta-analyses, Shiri and colleagues reported a significant association between obesity and low back pain, sciatica, and surgery for disk herniation. 9,10 Although intuitively it seems that the most obvious cause of obesity-related disk degeneration would be the greater mechanical loads imparted on the spine in heavier individuals, more recent research suggests a multifactorial origin. Additional explanations for the increased incidence of disk degeneration in obese individuals include obesity-related chronic inflammation, gene-environment interaction, and decreased blood supply to the disk leading to ischemic changes. The chronic inflammatory state associated with obesity likely plays a role in the development of disk degeneration. Adipocytes are the body's basic fat-building cells. Although serving as a reservoir for energy storage, adipocytes also have an endocrine function through the release of cytokines, termed adipokines. The most heavily researched of these adipokines is leptin. Higher levels of systemic adipokines have been associated the development and progression of osteoarthritis in multiple joints. In a study of patients undergoing knee arthroplasty and arthroscopy, Dumond et al noted that higher concentrations of leptin in arthritic joints correlated with BMI.
14 Furthermore, leptin has also been associated with the progression of osteoarthritis in the hand. 15 In the vertebral column, adipokines contribute to cell clustering and matrix degradation within the disk tissue.
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These findings suggest that adipokines play a role in the development of joint degeneration in both the axial and appendicular skeleton.
A gene-environment interaction may also contribute to the increased incidence of disk degeneration in the obese population. An arginine-to-tryptophan change in the COL9A3 gene (Trp 3allele) has been independently associated with disk degeneration and sciatica. 18, 19 In a cross-sectional study of 135 middleaged men, Solovieva et al reported a synergistic relationship between obesity and this Trp 3 allele for the development of decreased disk height, posterior disk bulge, and disk signal changes on magnetic resonance imaging. 18 This finding suggests that a genetic predisposition in a portion of the obese population may increase their risk of disk degenerative changes and potential back-related disability. Obese individuals may experience higher rates of spine pathology secondary to atherosclerotic and lipid-related disk ischemia. The blood supply to the intraosseous portion of the vertebral body is derived from the nutrient and metaphyseal arteries. 20 Each of these has centrifugal branches that terminate at the end plates and arise from the lumbar arteries, which branch directly from the aorta. 20 Having no direct blood supply, the intervertebral disk relies on diffusion from the adjacent vertebral bodies as its only source of nutrition and to expel cellular waste such as lactate. A compromise in this supply of nutrients, oxygen and waste expulsion at any point along the vascular tree reduces cellular viability and proteoglycan production, which leads to disk degeneration. 21 In two postmortem studies, calcification of the abdominal aorta and atherosclerotic stenosis of the lumbar arteries were correlated with an increased risk of disk degeneration and low back pain. 22, 23 Higher plasma levels of apolipoprotein E have also been associated with chronic lumbar pain. 24 As obesity has been linked with both apolipoprotein E and peripheral vascular disease, 25 the ischemia-related disk degeneration produced by these two risk factors may also contribute to the higher incidence of spine-related conditions in this population. Though the exact contribution each of these factors plays in the development of spine-related pain is not fully understood, the existing evidence suggests a multifactorial problem. Developing a more complete understanding of this phenomenon may improve existing theories on the development of disk degeneration and help identify novel therapies aimed at prevention of disk degeneration and neurologic compression in this population.
Effects on Postoperative Complications
Obesity has been associated with longer operative times, increased blood loss, increased treatment cost, higher risk of mortality, and higher rates of both surgical site infection and venous thromboembolism. 6, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] The complex relationship between increased rates of postoperative complications and obesity is likely at least partially dependent on confounding variables within this population. Obese patients undergoing spine surgery have higher rates of medical comorbidities, such as diabetes mellitus and coronary arterial disease, which serve as independent risk factors for postoperative adverse events. 5, 6, 35, 37 the total anesthetic and positioning time. Larger volumes of blood loss can lead to both higher rates of postoperative transfusion and hematoma formation, which have both been identified as risk factors for postoperative complications.
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The presence of obesity has been correlated with higher rates of postoperative infection in multiple investigations (►Table 1). 
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Though each of these investigations associated risk of infection with obesity (BMI > 30 kg/m 2 ), Mehta and colleagues suggested that the distribution of adipose tissue plays a significant role in the development of surgical site infection following spine surgery. 44, 46 To this end, the author found significant associations between infection and the skin-tolamina distance as well as the thickness of the subcutaneous tissue as measured on magnetic resonance imaging in cervical and lumbar procedures. 44, 46 These studies introduce the idea that body habitus, rather than BMI, may be a better predictor of surgical site infection, which may be particularly true in more muscular individuals with relatively high BMIs but little adipose tissue. Understanding this potential limitation in the use of BMI alone may help practicing spine surgeons better understand this elevated risk of postoperative infection.
Another commonly feared complication associated with obesity following spine surgery is venous thromboembolism. In the general population, obesity is an independent risk factor for both deep venous thrombosis and pulmonary embolism. 47, 48 This strong association is the result of (1) obesity-related chronic inflammation, (2) and EuroQol Group Index (EQ-5D) scores than normal weight patients (BMI < 25 kg/m 2 ; EQ-5D 0.56 versus 0.64, p < 0.001; ODI 33 versus 25, p < 0.001) and less mean improvement 2 years after surgery. 53 In this study, the obese population also experienced significantly greater risk for dissatisfaction with the results of surgery (OR: 1.73, 95% CI: 1.36 to 2.19). 53 In a review of patients undergoing surgery for lumbar disk herniation from the SPORT data, Rihn et al noted significantly less improvement in ODI and all components of the SF-36 scores as well as the Sciatica Bothersomeness and Low Back Pain Bothersomeness Indices in the obese population.
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Although these investigations provide contradictory information on whether obese patients experience less improvement with surgery, they should be interpreted carefully as obesity has been associated with worse baseline functional scores and less improvement with nonoperative treatment. 26 28, 37, 54 These differences in both baseline disability and response to nonoperative treatment limit the value of directly comparing long-term functional outcome measures in the obese and nonobese populations to determine the efficacy of surgery. In this context, it is more important to consider the treatment effect of operative intervention as a measure of therapeutic success. The treatment effect is defined as the difference between mean improvement in a surgical population compared with mean improvement associated with nonoperative treatment in a similar population. When considering this measure of success, obese patients have similar or better responses to operative intervention than their nonobese counterparts. 28, 37, 54 In examining this metric, the SPORT data likely provides the most complete insight due to the fact it represents a large prospective data set collected at multiple institutions (►Tables 3, 4, and 5). In a subgroup analysis of these results, Rihn et al reported equivalent surgical treatment effects in the obese and nonobese populations for lumbar disk herniation using SF-36 and ODI scores. 54 However, obese individuals had greater treatment effects with surgery in both the lumbar stenosis (SF-36 physical profile) and degenerative spondylolisthesis (ODI) populations. 28 The authors attributed these differences in treatment effect to the worse outcomes observed with nonoperative management in the obese group. Though controversy may persist on whether obese patients experience the same magnitude of functional improvement after surgery, the greater treatment effects noted indicate that surgery, 
Conclusion
With important differences in postoperative complication rates and response to both operative and nonoperative treatment, obese individuals represent a unique patient population. As the global incidence of obesity continues to rise, obese patients will likely constitute a larger portion of the spine surgeon's practice. Though the current literature points to increased rates of postoperative complications, particularly infection and venous thromboembolic events, there is also a suggestion of potentially greater treatment effects with surgical intervention owing largely to worse outcomes with nonoperative treatment. Future research in this field should examine measures to minimize the complication rates in this population as well as the effect of controlled weight loss before surgery on complications and outcomes. 
